Aspen Pharmacare Holdings Limited (APN.JO) JNB

12,122.00

-19(-0.16%)

Updated at January 14 02:25PM

Currency In ZAc

Aspen Pharmacare Holdings Limited

Address

Aspen Place

Durban,

South Africa

Phone

27 31 580 8600

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

8867

First IPO Date

January 04, 2000

Key Executives

NameTitlePayYear Born
Stephen Bradley SaadGroup CEO & Executive Director15.42M1964
Samer KassemChief Executive Officer of Aspen Global Incorporated01975
Trevor Julian ZimanRegional Chief Executive Officer of Asia Pacific01972
Michael Guy AttridgeGroup Chief Advisor8.15M1961
Lorraine HillGroup Chief Operations Officer11.15M1964
Reginald HamanGroup Chief Corporate Officer & Executive Director11.31M1975
Sean CapazorioGroup CFO & Executive Director12.27M1967
Luresha ChettyCorporate Affairs & Investor Relations Executive0N/A
Raeesa KhanGroup Company Secretary & Chief of Staff01991
Sibongakonke NkosiInvestor Relations Manager0N/A

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.